FindTrial
Sign In

Effect of dexmedetomidine on perioperative period in patients with oral squamous cell carcinoma

Effect of dexmedetomidine on perioperative period in patients with oral squamous cell carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018367
Enrollment
Unknown
Registered
2018-09-13
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral squamous cell carcinoma

Interventions

Dex group:use dexmedetomidine during operation
control group:do not use dexmedetomidine during operation

Sponsors

Stomatological Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 60 patients with oral squamous cell carcinoma undergoing radical mastectomy and simultaneous flap defect repair; aged 40-70 years; ASAI-II grade; TNM stage 0-1

Exclusion criteria

Exclusion criteria: Patients with sinus bradycardia, unstable blood pressure, and allergies to dexmedetomidine

Design outcomes

Primary

MeasureTime frame
Anesthetic dosage;Postoperative shiver;Postoperative agitation;Postoperative delirium;—

Countries

China

Contacts

Public ContactHuang Lili

Stomatological Hospital of Wuhan University

1073457191@qq.com+86 18607103117

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026